Andrew M. Lowy, MD is a surgical oncologist with expertise in treating cancers of the pancreas, liver and GI tract. Dr. Lowy is recognized worldwide for his expertise in pancreatic cancer surgery and in the management of complex gastrointestinal cancers. He is also known for investigating novel cancer treatments, including heated intraperitoneal chemotherapy (HIPEC), to treat advanced abdominal cancers.

Dr. Lowy is a professor in the Department of Surgery and chief of the Division of Surgical Oncology at UC San Diego School of Medicine. His research program, which focuses on pancreatic and peritoneal metastasis, has received funding from the National Cancer Institute, Stand-Up-To-Cancer, The Lustgarten Foundation, AACR/PANCAN, and the National Organization of Rare Diseases. He currently serves as the surgical principal investigator for the largest pancreatic cancer clinical trial ever conducted in the United States.

A frequent speaker at national and international meetings, Dr. Lowy has coauthored numerous textbooks, book chapters and peer-reviewed articles, and serves on the editorial board of Annals of Surgical Oncology.

He completed a surgical fellowship at University of Texas, MD Anderson Cancer Center, and residency training at Cornell Medical Center and Memorial Sloan Kettering Cancer Center. He earned his medical degree from Cornell University Medical College. He is board-certified in surgery and a Fellow of the American College of Surgeons (FACS).

Dr. Lowy has repeatedly been named a top doctor in San Diego Magazine’s “Physicians of Exceptional Excellence" annual survey performed in collaboration with the San Diego County Medical Society.